William Sauer, MD
Cardiovascular Disease · Aurora, CONPI 1609827583
Payments from drug & device makers
Across 517 payments — averaging $1891.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$615K
- Medtronic$123K
- Abbott$84K
- Biotronik Inc.$66K
- Boston Scientific$61K
- Medical Device Business Services, Inc.$28K
- plus $1K from 5 others
What the payments were for
- Consulting fees$183,10850%
- Speaking & faculty fees$112,02831%
- Travel & lodging$48,67713%
- Food & beverage$21,3166%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 107 | $615,491 |
| Medtronic(2 entities) | 19 | $123,164 |
| Abbott | 162 | $83,633 |
| Biotronik Inc. | 141 | $65,634 |
| Boston Scientific | 51 | $60,865 |
| Medical Device Business Services, Inc. | 31 | $27,554 |
| Siemens Medical Solutions USA, Inc. | 2 | $1,084 |
| Atricure, Inc. | 1 | $163 |
| Volta Medical Inc | 1 | $109 |
| Cardiva Medical, Inc. | 1 | $29 |
| Irhythm Technologies, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$108,100
- ENSITE$37,262
- GENERAL - THERAPIES$23,623
- ENSITE PRECISION$14,822
- Ensite Cardiac Mapping System$14,699
- EnSite Precision Cardiac Mapping System$12,190
- Carto 3 System$11,864
- Acticor$11,765
- Edora$11,765
- Rivacor$11,765
- Sentus$9,551
- Plexa$8,758
- Thermocool SF$7,594
- CLINICAL TRIAL PRODUCT$3,800
- Solia$3,745
- BioMonitor$3,574
- ENDURITY$900
- Edora 8 DR-T$567
- Acticor 7 VR-T DX$567
- Rivacor 7 DR-T$567
How this compares
$977,754 in reported general payments places this provider in the 95th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Flecainide Acetate | 13 | $1,174 |
| Metoprolol Succinate | 13 | $286 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Aurora
- Payal KohliAurora$1.7M
- Marc BonacaAurora$1.2M
- Brack HattlerAurora$699K
- John OrdAurora$176K
- Steven SimonAurora$168K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Edward GillAurora$96K
- Luisa MestroniAurora$80K
- Joseph AdewumiAurora$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.